Loading stock data…
OPK
$1.10-0.03 (-2.22%)
Market ClosedLast close May 1
OPKO Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
OPKO Health, Inc. in the Healthcare sector is trading at $1.10. The stock is currently near its 52-week low of $0.98, remaining 16.7% below its 200-day moving average. Technical signals show neutral RSI of 39 and bearish MACD signal, explaining why OPK maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 39) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.10
Potential Upside
5%
Whystock Fair Value$1.16
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Buy
Mean target$3.76+241.8%
Range$1.30 – $8.50
Fundamentals
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$936.60M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.49
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-13.97%
Volume
Today's trading volume
1.95M
Recent News
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.
OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
Despite revenue setbacks, OPKO Health Inc (OPK) shows resilience with strategic advancements and a strong cash position.
OPKO Health Q1 Earnings Call Highlights
OPKO Health (NASDAQ:OPK) reported first-quarter 2026 results and highlighted continued progress across its ModeX Therapeutics pipeline, along with ongoing restructuring in diagnostics and growth in international pharmaceutical operations. ModeX pipeline expands clinical activity and partnerships Ch
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of -2.94% and -4.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.